Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 4 - Future Directions for ART Surveillance and Monitoring Novel Technology

  • from Section 2 - General Principles of ART Surveillance
  • Edited by Dmitry M. Kissin, G. David Adamson, Georgina Chambers, Christian De Geyter
  • Book:
    Assisted Reproductive Technology Surveillance
    Published online:
    14 June 2019
    Print publication:
    04 July 2019, pp 31-36

  • Summary

    In many areas activities in assisted reproductive technology (ART) are being recorded and analyzed by registries, either on a voluntary or compulsory basis , and reports are generated producing cross-sectional data on an annual basis. Current ART is now developing towards a segmented longitudinal approach, in which single therapeutic steps are spread over prolonged time intervals, necessitating a cumulative approach in the handling of ART-data. This requires a unique identifier for each individual seeking fertility care together with an informed and signed consent. The identifier should reside with the institution offering fertility treatment and follow the infertile individual through the various therapeutic steps, even if leaving to another institution. The identifier should be added to all data submitted to the ART registry. This will allow the national health register to construct cumulative outcome data on all forms of fertility treatment, including long-term gamete and tissue freezing-related information.